{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T15:18:56Z","timestamp":1726759136141},"reference-count":25,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2071,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1399-3046.2009.01285.x","type":"journal-article","created":{"date-parts":[[2009,12,31]],"date-time":"2009-12-31T00:51:48Z","timestamp":1262220708000},"page":"618-621","source":"Crossref","is-referenced-by-count":9,"title":["Low incidence of hepatic veno-occlusive disease in pediatric patients undergoing hematopoietic stem cell transplantation attributed to a combination of intravenous heparin, oral glutamine, and ursodiol at a single transplant institution"],"prefix":"10.1111","volume":"14","author":[{"given":"Sonali","family":"Lakshminarayanan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indira","family":"Sahdev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meena","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrianna","family":"Vlachos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Atlas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M.","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,12,30]]},"reference":[{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB1|cit1","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: Incidence, clinical course and outcome","author":"Coppell","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.transproceed.2005.03.025","article-title":"Time-related changes in the incidence, severity, and clinical outcome of hepatic veno-occlusive disease in hematopoietic stem cell transplantation patients during the past 10\u2003years","volume":"37","author":"Kalayoglu-Besisik","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB3|cit3","first-page":"197","article-title":"Hepatic veno-occlusive disease-liver toxicity syndrome after bone marrow transplantation","volume":"10","author":"Shulman","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.bmt.1701506","article-title":"Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: Incidence, onset time and risk factors","volume":"22","author":"Hasegawa","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","article-title":"The syndrome of hepatic veno-occlusive disease after marrow transplantation","volume":"85","author":"Bearman","year":"1995","journal-title":"Blood"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","article-title":"Veno-occlusive disease of the liver after bone marrow transplantation: Diagnosis, incidence, and predisposing factors","volume":"4","author":"McDonald","year":"1984","journal-title":"Hepatology"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB7|cit7","first-page":"135","article-title":"Risk factors for hepatic veno-occlusive disease after high dose busulfan-containing regimens followed by autologous bone marrow transplantation: A study in 136 children","volume":"10","author":"Meresse","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1182\/blood-2003-01-0255","article-title":"Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation","volume":"102","author":"Wadleigh","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.leukres.2006.07.005","article-title":"Gemtuzumab ozogamicin- associated sinusoidal obstructive syndrome (SOS): An overview from the research on adverse drug events and reports (RADAR) project","volume":"31","author":"McKoy","year":"2007","journal-title":"Leuk Res"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.bmt.1705835","article-title":"Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation","volume":"40","author":"Cheuk","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB11|cit11","first-page":"407","article-title":"A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation","volume":"5","author":"Bearman","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1182\/blood.V79.11.2834.bloodjournal79112834","article-title":"Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial","volume":"79","author":"Attal","year":"1992","journal-title":"Blood"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbmt.2006.09.012","article-title":"Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation","volume":"13","author":"Tay","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1182\/blood-2001-12-0159","article-title":"Ursodeoycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation","volume":"100","author":"Ruutu","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<32::AID-AJH6>3.0.CO;2-N","article-title":"The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation","volume":"64","author":"Ohashi","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.bmt.1703342","article-title":"A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation","volume":"29","author":"Park","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.bmt.1701172","article-title":"Glutamine and vitamin E in the treatment of hepatic veno-occlusive disease following high dose chemotherapy","volume":"21","author":"Goringe","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1365-2141.1993.tb03152.x","article-title":"A phase I\/II study of prostaglandin E1 for the prevention of hepatic veno-occlusive disease after bone marrow transplantation","volume":"84","author":"Bearman","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB19|cit19","first-page":"795","article-title":"Hepatic veno-occlusive disease in pediatric stem cell transplantation: Impact of pre-emptive antithrombin III replacement and combined anti-thrombin III\/defibrotide therapy","volume":"91","author":"Hausmann","year":"2006","journal-title":"Haematologica"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.bmt.1705485","article-title":"Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD which could be prevented with defibrotide","volume":"38","author":"Corbacioglu","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.bmt.1705696","article-title":"Prophylactic defibrotide in allogeneic stem cell transplantation: Minimal morbidity and zero mortality from veno-occlusive disease","volume":"40","author":"Dignan","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/pbc.21425","article-title":"Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children","volume":"50","author":"Qureshi","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/pbc.20934","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease in children","volume":"48","author":"Bulley","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","article-title":"Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: Response without significant toxicity in a high-risk population and factors predictive of outcome","volume":"100","author":"Richardson","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1399-3046.2009.01285.x-BIB25|cit25","first-page":"699","article-title":"A statistical model to predict unfavorable outcome in patients with veno-occlusive disease of the liver after marrow transplant","volume":"18","author":"Bearman","year":"1990","journal-title":"Exp Hematol"}],"container-title":["Pediatric Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3046.2009.01285.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1399-3046.2009.01285.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T01:53:00Z","timestamp":1625622780000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3046.2009.01285.x"}},"subtitle":["Prevention of hepatic VOD by a three-drug regimen"],"short-title":[],"issued":{"date-parts":[[2009,12,30]]},"references-count":25,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1111\/j.1399-3046.2009.01285.x","relation":{},"ISSN":["1397-3142","1399-3046"],"issn-type":[{"value":"1397-3142","type":"print"},{"value":"1399-3046","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,30]]}}}